Elucidating CTLA-4’s role in tumor immunity: a comprehensive overview of targeted antibody therapies and clinical developments
Crossref DOI link: https://doi.org/10.1007/s11030-024-10917-6
Published Online: 2024-07-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fu, Juan
Mao, Lin
Jiao, Yu
Mei, Desheng
Chen, Yadong
Text and Data Mining valid from 2024-07-10
Version of Record valid from 2024-07-10
Article History
Received: 17 April 2024
Accepted: 11 June 2024
First Online: 10 July 2024
Declarations
:
: The authors declare no competing interests.